Structure Therapeutics Stock Target Price and Analyst Consensus
| GPCR Stock | 36.02 0.32 0.90% |
The current analyst and expert consensus on Structure Therapeutics is Strong Buy, with 4 strong buy opinions. The current projected Structure Therapeutics target price consensus is 83.17 with 7 analyst opinions. The most common way Structure Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Structure Therapeutics executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Structure Therapeutics. We strongly encourage you to use your own analysis of Structure Therapeutics to validate this buy or sell advice. Structure Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Structure Therapeutics target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Structure Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Lowest Forecast 75.68 | Highest Forecast 92.32 | Target Price 83.17 |
Structure |
It's important to approach Structure Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Structure Therapeutics Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Structure target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Structure Therapeutics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 7 | Strong Buy |
Most Structure analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Structure stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Structure Therapeutics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationStructure Therapeutics Target Price Projection
Structure Therapeutics' current and average target prices are 36.02 and 83.17, respectively. The current price of Structure Therapeutics is the price at which Structure Therapeutics American is currently trading. On the other hand, Structure Therapeutics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Structure Therapeutics Market Quote on 15th of May 2024
Target Price
Analyst Consensus On Structure Therapeutics Target Price
Structure Therapeutics Analyst Ratings
Structure Therapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Structure Therapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Structure Therapeutics' financials, market performance, and future outlook by experienced professionals. Structure Therapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Structure Therapeutics price targets
Structure Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Structure Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Structure Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Structure Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Structure Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Structure Therapeutics is a key component of Structure Therapeutics valuation and have some predictive power on the future returns of a Structure Therapeutics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Structure Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Corona Opportunity Invested few shares | |
 | Business Services Invested few shares | |
 | Chemicals Invested over 30 shares | |
 | Hedge Favorites Invested few shares | |
 | Dividend Beast Invested over 60 shares | |
 | Momentum Invested over 200 shares | |
 | Macroaxis Index Invested few shares | |
 | Transportation Invested over 20 shares | |
Check out Macroaxis Advice on Structure Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Structure Therapeutics information on this page should be used as a complementary analysis to other Structure Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Complementary Tools for Structure Stock analysis
When running Structure Therapeutics' price analysis, check to measure Structure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Structure Therapeutics is operating at the current time. Most of Structure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Structure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Structure Therapeutics' price. Additionally, you may evaluate how the addition of Structure Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |
The data published in Structure Therapeutics' official financial statements usually reflect Structure Therapeutics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Structure Therapeutics. For example, before you start analyzing numbers published by Structure accountants, it's critical to develop an understanding of what Structure Therapeutics' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Structure Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Structure Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Structure Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Structure Therapeutics American. Please utilize our Beneish M Score to check the likelihood of Structure Therapeutics' management manipulating its earnings.